よむ、つかう、まなぶ。
04 参考資料1-123価肺炎球菌莢膜ポリサッカライドワクチン(肺炎球菌ワクチン)ファクトシート (34 ページ)
出典
公開元URL | https://www.mhlw.go.jp/stf/newpage_36630.html |
出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会(第22回 12/1)《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
討ワーキンググループ. 成人予防接種のガイダンス 2016 年改訂版. 日本内科学会雑誌 8;
1472-88, 2016.
76.Konomura K, Nagai H, Akazawa M. Economic burden of community-acquired pneumonia among
elderly patients: a Japanese perspective. Pneumonia (Nathan). 5;9:19,2017.
77.Takaki M, Nakama T, Ishida M, Morimoto H, Nagasaki Y, Shiramizu R, et al. High incidence
of community-acquired pneumonia among rapidly aging population in Japan: a prospective
hospital-based surveillance. Jpn J Infect Dis. 67(4): 269-75,2014.
78.厚生労働省. 予防接種情報
定期の予防接種実施者数.
[URL: http://www.mhlw.go.jp/topics/bcg/other/5.html]
79.Fedson DS, Nicolas-Spony L, Klemets P, van der Linden M, Marques A, Salleras L, et al.
Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe. Expert
Rev Vaccines. 10:1143-67,2011.
80.The Australian Immunisation Handbook 10th edition (updated August 2017). 4.13 PNEUMOCOCCAL
DISEASE. 1-21.
81.Ho PL, Miyaji EN, Oliveira ML, Dias Wde O, Kubrusly FS, Tanizaki MM, Martins EA, Raw I.
Economical value of vaccines for the developing countries--the case of Instituto Butantan,
a public institution in Brazil. PLoS Negl Trop Dis. Nov;5(11):e1300. 2011.
82.Center for Disease Control. Prevention of pneumococcal diseases: Recommendation of
Advisory
Committee
on
Immunization
Practice.
MMWR
46:1-23,
Pneumococcal
disease.
1997. (https://www.cdc.gov/mmwr/preview/mmwrhtml/00047135.htm)
83.The
Australian
Immunisation
Handbook,
4.13
(http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/9234F08B6
DE9BB34CA257D4D00234E27/$File/4-13-Pneumococcal.pdf)
84.Pneumococcal:
the
green
book,
chapter
25
(https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/596441/gre
en_book_chapter__25.pdf)
85.Falkenhorst G, Remschmidt C, Harder T, Wichmann O, Glodny S, Hummers-Pradier E, et al.
Background paper to the updated pneumococcal vaccination recommendation for older adults
in
Germany.
Bundesgesundheitsblatt
Gesundheitsforschung
(12):1623-57, 2016.い8くj
33
Gesundheitsschutz.
59
1472-88, 2016.
76.Konomura K, Nagai H, Akazawa M. Economic burden of community-acquired pneumonia among
elderly patients: a Japanese perspective. Pneumonia (Nathan). 5;9:19,2017.
77.Takaki M, Nakama T, Ishida M, Morimoto H, Nagasaki Y, Shiramizu R, et al. High incidence
of community-acquired pneumonia among rapidly aging population in Japan: a prospective
hospital-based surveillance. Jpn J Infect Dis. 67(4): 269-75,2014.
78.厚生労働省. 予防接種情報
定期の予防接種実施者数.
[URL: http://www.mhlw.go.jp/topics/bcg/other/5.html]
79.Fedson DS, Nicolas-Spony L, Klemets P, van der Linden M, Marques A, Salleras L, et al.
Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe. Expert
Rev Vaccines. 10:1143-67,2011.
80.The Australian Immunisation Handbook 10th edition (updated August 2017). 4.13 PNEUMOCOCCAL
DISEASE. 1-21.
81.Ho PL, Miyaji EN, Oliveira ML, Dias Wde O, Kubrusly FS, Tanizaki MM, Martins EA, Raw I.
Economical value of vaccines for the developing countries--the case of Instituto Butantan,
a public institution in Brazil. PLoS Negl Trop Dis. Nov;5(11):e1300. 2011.
82.Center for Disease Control. Prevention of pneumococcal diseases: Recommendation of
Advisory
Committee
on
Immunization
Practice.
MMWR
46:1-23,
Pneumococcal
disease.
1997. (https://www.cdc.gov/mmwr/preview/mmwrhtml/00047135.htm)
83.The
Australian
Immunisation
Handbook,
4.13
(http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/9234F08B6
DE9BB34CA257D4D00234E27/$File/4-13-Pneumococcal.pdf)
84.Pneumococcal:
the
green
book,
chapter
25
(https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/596441/gre
en_book_chapter__25.pdf)
85.Falkenhorst G, Remschmidt C, Harder T, Wichmann O, Glodny S, Hummers-Pradier E, et al.
Background paper to the updated pneumococcal vaccination recommendation for older adults
in
Germany.
Bundesgesundheitsblatt
Gesundheitsforschung
(12):1623-57, 2016.い8くj
33
Gesundheitsschutz.
59